Analyst Coverage

Aimmune Therapeutics is covered by the following analysts:
Firm Analyst
Bank of America Merrill Lynch
Ying Huang, Ph.D.
Cantor Fitzgerald
Charles Duncan Ph.D.
Credit Suisse
Vamil Divan, M.D.
Goldman Sachs
Paul Choi
JMP Securities
Liisa Bayko
Piper Jaffray
Christopher Raymond
RBC Capital Markets, LLC
Kennen MacKay, Ph.D.
Robert W. Baird & Co.
Brian Skorney, CFA
Roth Capital Partners, LLC
Jotin Marango, M.D., Ph.D.
Derek Archila
Wedbush Securities
Liana Moussatos, Ph.D.
Any opinions, estimates or forecasts regarding Aimmune’s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Aimmune or its leadership team. Aimmune does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.